Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 21 May 2025
Women’s and reproductive health guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC